INTRODUCTION
likely that similar considerations will be important in cell replacement in other neurodegenerative conditions such as HD, a progressive incurable neurodegenerative Transplantation of human fetal central nervous system (CNS) tissue has been shown to be of benefit in Parkin-condition in which the burden of pathology is (at least in the early to moderate stages) in the neostriatum. son's disease (PD) (8, 25, 28) and is being explored as a possible therapeutic intervention for Huntington's dis-HD is a dominantly inherited condition in which there is a triplet repeat expansion in the N-terminal end of a ease (HD) (14, 31) . To date, only primary fetal tissue has been proven to be effective in amelioration of functional gene on chromosome 4 (20) . The molecular and cellular events that cause the mutant huntingtin protein to pro-deficits in clinical studies, although there is an intense search for alternative cells for transplantation (13) . The duce disease are not yet fully understood, although there has been considerable progress in this direction over the success of transplanting human fetal tissue in patients with advanced PD depends on taking careful account of last few years (17) . It is hoped that a fuller understanding of these events will lead eventually to the develop-a number of factors, including the gestational age of the tissue and the preparation of the donor cells (5). Specifi-ment of interventions to slow or halt disease progression. An alternative approach to the treatment of this cally, the cells need to be collected from fetuses of approximately 6-9 weeks postconception, and must be condition is to consider replacement of the damaged neurons by transplantation of primary fetal striatal tis-transplanted within approximately 6 h of collection, unless subject to a validated storage protocol (21, 37) . It is sue. There is now a considerable amount of data demon-strating that this approach can ameliorate functional def-only be finally determined by carefully conducted clinical studies. icits in animal models of HD (10). There have been relatively few clinical studies of neural transplantation Consistent and reliable isolation of neural tissue from human fetal material obtained through elective termina-in HD worldwide [reviewed in (36)], but three groups have published studies suggesting that transplantation in tion of pregnancy (TOP) is a prerequisite for local phase 1 clinical trials of transplantation on HD. Furthermore, HD is both safe and feasible (1, 24, 35) . A fourth group has reported graft survival (19) , but also subdural hema-due to the small numbers of patients with HD worldwide receiving neural transplants, it is crucial that data are tomas in three out of seven patients (18) , which may have related to the fact that these patients had relatively standardized and reliable so that meaningful comparisons can be made between centers. Thus, protocols for tissue advanced disease with more marked cortical atrophy, a known risk factor for postoperative subdural bleeding.
preparation, including accurate staging of embryos, need to be achieved using methods that are readily available Bachoud-Lévi and colleagues published the outcome of five patients, 2 years after receiving staged bilateral im-and can be standardized between centers. Our own UK study (ISRCTN No. 36485475) is a safety study of four plants of human fetal striatal tissue, and suggested preliminary evidence of clinical benefit (2). patients, and is in collaboration with the group of Peschanski, Bachoud-Lévi, and colleagues as part of a Euro-Although many of the tissue preparation parameters for neural transplantation in HD have been determined pean Network for Striatal Transplantation in Huntington's Disease (NEST-HD). We report here the detailed in animal studies (9), some, such as the optimum gestational age for donor tissue, are yet to be fully resolved. protocols used to collect and prepare tissue in the UK trial, and describe the use and validation of a method There is now a general acceptance of the principle that the optimal donor stage for transplantation is during em-for estimation of gestational age based on the work of Evtouchenko and colleagues (11) in which an algorithm bryonic development when the most relevant cells are in the process of differentiation, but have not begun axonal was presented to estimate gestational age and crownrump length from the measurement of fetal parts. development (3). Animal models were used to produce an estimate of the optimal age of donor tissue for PD MATERIALS AND METHODS and subsequently used to guide clinical studies (5). In Ethics and Consent Procedures the rat, Fricker and colleagues (15) demonstrated that optimal recovery on a number of behavioral tests in a
In the UK, human fetal tissue is collected according to the Polkinghorne and Department of Health guide-HD rat model is produced following transplantation of E14 striatal tissue (Carnegie stage 18). These grafts also lines (7,32). Similar guidelines are available in many countries, and international guidelines are also available had the highest proportion of striatal-like tissue. In the marmoset, functional recovery has been demonstrated (4). All emphasize the need to separate the clinical management and counseling of the maternal donor from the with tissue of 13-16 mm crown-rump length (i.e., 73-75 days of gestation) (Carnegie stage 18-21) (23). process of collection and use of the fetal tissues. To obtain permission to collect tissue in Cambridge, our Local Thus, work using two species points to a Carnegie stage of around 18-21 as optimal, which in humans corre-Research Ethics Committee was particularly concerned about two issues: (i) how to maintain separation of the sponds to embryos of crown-rump length 13-24 mm (i.e., 44-53 days postconception). However, as the stria-collection of consent from the maternal donor for collection of tissue, and (ii) how to address the issue of tal anlage is only dissectable in human material from 20 mm, this window of opportunity may turn out to be at HIV testing, given that, at the time of collection, HIV tests were not routinely performed in pregnant women slightly later Carnegie stages in the human. This issue has not been addressed directly in animal models using in the UK. The first issue was addressed by the appointment of human fetal tissue as the donor tissue, although the few studies to date using human tissue have suggested an a part-time research nurse, employed on a grant raised by the research team, but subject to independent line man-extended window of opportunity: surviving grafts have been reported from 21-30-mm (16), 34-36-mm (26) , agement by the Department of Obstetrics and Gynaecology. This nurse was neither involved in the patients' and even up to 110-mm embryos (34) . In the latter study, reduction of apomorphine-induced rotation was clinical management nor involved in the collection or use of the tissue. Only after a woman had made the deci-also reported (33) . Our own preliminary studies of human fetal tissue transplanted into the excitotoxically le-sion to proceed with a surgical TOP and had signed consent for this procedure was she invited by the doctor in sioned rat striatum have suggested a window of 66 and 82 days postconception as optimum in terms of graft the clinic to consider contributing to the research project. Women whose capacity to fully understand the con-volume (21) , although further empirical studies are required to properly define this time window, and it will sent issues was in doubt (e.g., due to a language barrier) or who appeared to be unduly distressed were not in-taining commercial hibernation medium (Hibernate E, Invitrogen), phosphate-buffered saline (PBS)/glucose vited to explore their involvement further. Women who expressed an interest in being involved in the project (0.6%), and heparin, and transported to the laboratory on ice. were seen by the research nurse, who explained the rationale for tissue collection, abdominal ultrasound, and Maternal donor serum was tested for a range of pathogens, as described by Farrington and colleagues (12). low-pressure TOP according to standard procedures in the UK, and undertook consent for tissue donation. The
The results of this screen are available prior to tissue collection, and in the case of a serious infection risk, the nurse could be contacted up to the time of surgery, so that women could ask any further questions or withdraw tissue collected would be abandoned. from tissue donation. No explanation was required for Tissue Dissection and Preparation withdrawal of consent. Patients were not free to direct the specific use of tissues, and it was made clear that
The tissue was dissected under sterile conditions in a BioMAT2 class II tissue culture hood (Medical Air Tech-tissue might be used for biological research, clinical transplantation, or might not be suitable for use in either nology, Manchester, UK) with a built-in Leica MZ75 dissecting microscope, whereby the binocular eyepiece case.
The second issue was addressed in two ways. First, tubes pass through a seal in the front window to maintain sterility. Tissue for clinical use was always dis-potential donors were asked to read a self-exclusion questionnaire that had been adapted from the well-vali-sected in the presence of at least two senior members of the research team with 5 or more years of experience of dated questionnaire used routinely in the UK Blood Transfusion Service to identify individuals at risk of embryonic CNS dissection in a variety of species. Tissue was only used for clinical purposes if all dissectors were contracting HIV. Individuals are asked to withdraw from tissue donation, without question of the reasons, if they satisfied that striatum had been clearly identified (see Fig. 2 ). The microscopic dissection was recorded by answer any of the questions affirmatively. Counseling was available for any patient anxious about the risk of video and the tape from each dissection archived for reference. having contracted HIV. Second, blood samples were taken and identified using a random code so that none Embryonic parts were staged according to the model of Evtouchenko and colleagues (11) as described below. of the clinical management team, the pathology laboratory, or the research team would be able to identify a Prior to the launch of the clinical transplantation program, the accuracy of the dissection was verified experimen-maternal donor who had tested positive for either HIV or hepatitis B or C. The codes were held securely in the tally by DARPP32 staining of the presumptive striatal tissue (i) after fixation and sectioning of the embryonic Department of GU medicine and would only be made available to doctors and counselors in that department brain fragments, (ii) following standard tissue culture, and (iii) following transplantation into the quinolinic in the case of a positive test so that the individual could be followed up and offered advice and management.
acid-lesioned striatum of athymic rats. Once the striatum had been positively identified and Permission to collect tissue in this manner was obtained from the Cambridge Local Research Ethics Committee dissected free from the brain, the tissue was diced into small pieces (ϳ1 mm 3 ), placed in fresh hibernation me-(LREC) in 1996 and renewed in 2000. dium, and stored at 4°C for up to 8 days prior to trans-Tissue Collection plantation (22) , although in most cases tissue was transplanted within 2 days of collection (35). Tissue was collected during routine suction TOP with the aid of abdominal ultrasound. No modifications were On the day of transplantation, the tissue was taken through four washes of sterile PBS supplemented with made to any of the instruments or standard procedures normally used in the UK. High-pressure suction in-0.6% glucose. Worthington trypsin 240 U was added for 15 min at 37°C. DNase (0.008%) and 0.1% trypsin in-volved the attachment of the collection catheter to an automated high-pressure vacuum, and low-pressure suc-hibitor were then added to the tissue and trypsin at a ratio of 1:1:1 for 5 min at room temperature. The tissue tion employed the use of a bladder syringe to exert a vacuum on the collection catheter. Currently it is not was then spun at 1000 rpm for 3 min. The supernatant was removed and the tissue washed once in DMEM. clear whether one method has advantages to the subject undergoing TOP, and there are no reports in the litera-Finally, 0.2 ml of grafting medium (DMEM plus 0.001% DNase) was added and the tissue triturated gently 10-15 ture of an excess of complications attached to either method. All protocols were explicitly approved by the times using a 200-µl Gilson yellow tip. This resulted in a coarse cell suspension, a small aliquot of which was LREC.
Following extraction, the products of conception taken for cell counts and an assessment of viability using trypan dye exclusion. The suspension was only used if were discharged into a sterile 50-ml centrifuge tube con-the viability was greater than 80%. The ganglionic emi-sulted in considerable fragmentation of the fetus, and out of 111 consecutive specimens, we were able to iden-nence was suspended in a volume of 40 µl to give a final cell density of at least 100,000 cells/µl. Samples tify fetal parts in only 53% and neural tissue in 45% of cases (Fig. 1) . The forebrain appeared particularly prone were sent for microbiological assessment at every stage of the procedure (12). A further separate piece of CNS to fragmentation and discrete structures in the telencephalon and diencephalon could only rarely be identified tissue was taken and stored at −80°C for archive purposes in case of unforeseen complications (e.g., in the anatomically. Indeed, striatal tissue was positively identified in only 1 of the 111 cases. Thus, this method was case of any recipient developing a prion infection).
The validity of this approach was verified prior to the clearly inadequate to support a clinical transplantation program that relied on the consistent identification of start of the clinical trial. Microbiological tissue samples were analyzed from multiple tissue collections to verify the developing striatum. The collection of tissue with a low-pressure vacuum that the techniques used were appropriate and reproducible (12). This included 5 full "dry runs" in which tissue directly into a bladder syringe was guided by the use of abdominal ultrasound. This technique has been associ-was taken from collection to the point of final preparation for grafting. ated with the effective collection of human fetal tissue for similar purposes in other centers (27) and resulted Staging of Embryos here in confident recovery of striatal tissue in 34% of Estimation of human fetal gestational age can be the first 86 cases (Fig. 1) . The accumulated expertise of made in a number of ways. Estimated time from the last a surgeon who was committed to the program was also menstrual period (LMP) is the most commonly used and considered important for the marked improvement in tiswidespread method, but is known to be subject to a sue recovery levels, and subsequently the recovery of number of errors, including inaccuracy of recording striatum continues at the level of approximately 30by the maternal donor and variation in cycle length, so 40%. that the relationship of LMP to the actual time of con-Assessment of Embryonic Age ception is variable. Ultrasound provides a more reliable method, although this too is subject to error, and this
The pairwise correlations between alternative estitends to be greater with younger and smaller fetuses. A mates of fetal age as determined by morphometric meafurther method of dating tissues between 4 and 12 weeks surement, ultrasound of crown-rump length, and LMP postconception has been suggested by Evtouchenko et are shown in Figure 3 . All three correlations were signifal. (11) based on a number of easily measured morphoicant, although the correlation between morphometry metric characteristics of retrieved tissue that may proand ultrasound was highest ( Fig. 3a -c: morphometry vs. vide a more reliable way of determining gestational age.
ultrasound, Pearson correlation coefficient, r = 0.80; This method allows for the estimation of crown-rump LMP vs. morphometry, r = 0.68; LMP vs. ultrasound, length based on the measurement of fetal parts, which is r = 0.62; all p < 0.001). necessary as the fetal tissue is typically fragmented dur-Using the procedures described here, we have deming the collection process. To compare these different onstrated cell survival following transplantation into an approaches of estimating embryonic age, we prospecanimal model of Huntington's disease (21, 22) . When tistively collected data on consecutive samples to assess sue was prepared for implantation into patients, it was these morphometric measurements as well as crowntransported to the surgical theater on ice and transported rump length on abdominal ultrasound and the date of according to the procedure of Watts et al. (38) . Viability, the LMP. assessed using trypan blue exclusion just prior to surgery, demonstrated cell viability to be between 82% and RESULTS
90%, and cells resulted in graft masses visible on MR Collection of Fetal Tissue
imaging at 6 months postoperatively (35). Human fetal tissue was initially collected using high-DISCUSSION pressure vacuum as this approach was already being used for collection of placental material for research purposes
In the present article we describe in detail our protocols for collection, dissection, and staging of human fe-in the same center. During this procedure the products of conception pass through approximately 1 m of flexi-tal tissue for transplantation in HD, as they exist at the end of the first stage of the NEST-UK safety trial (35). ble tubing into a sterile container. The products were then transferred to a tissue culture hood and emptied
We accept that it is likely that these protocols will continue to evolve, as we learn more from the results of into a nylon sieve, washed with ice-cold PBS/glucose, and examined for neural tissue. Although suitable for this surgery and adapt our procedures to increase their effectiveness. Part of this process will involve compari-collecting placental materials, this method of TOP re- Figure 1 . Effect of aspiration pressure on the collection and ability to identify fetal parts, fetal CNS, and specific neural tissues, including the striatum, which is critical for transplantation in Huntington's disease. The data are based on the first 111 cases collected by standard high-pressure aspiration and the subsequent first 86 cases collected by low-pressure aspiration, in which fetal tissues were sought. son of results between neural transplant centers, and is that individuals are identified who are willing to commit to training and building experience to act as the des-hence the importance of the existence of detailed protocols to enable this process of comparison to take place.
ignated surgeons for tissue collection for the program on a regular basis. Thus, successful extraction of tissue us-The success of a neural transplantation depends on the quality of the donor tissue, in particular that the rele-ing low-pressure methods and ultrasound requires practice and also a commitment to the additional care neces-vant brain region can be positively identified and accurately dissected, and the tissue is prepared to maintain sary, as the procedure takes approximately 10 min extra per patient, which is a small additional time cost but can cell viability. When high pressures are used to remove the products of conception during TOP, extreme frag-be significant on a long surgical list. In addition to the measures taken to increase the yield mentation of the tissue occurs and it becomes essentially impossible (at least in our judgment) to identify striatum of identifiable striatal tissue from the embryonic brain, multiple analyses of dissected tissue prior to the launch with any confidence. This is compounded by the fact that the tissues are discharged through a length of tubing to of the clinical program confirmed that the anatomical landmarks were valid and that the dissections were accu-a collecting vessel. It is important that tissue is removed gently to preserve as much of the anatomy as possible to rate and did not include detectable amounts of tissue other than the presumptive striatum. aid confident identification. Using a low-pressure TOP guided by abdominal ultrasound we were able to iden-In the light of experimental evidence suggesting the importance of embryonic age to graft viability, it becomes tify the developing striatum using anatomical landmarks in a significant proportion of cases. This emphasis on imperative to refine criteria for accurate staging of embryos to be used for human transplant trials. In view of low-pressure aspiration has been reported by many centers involved in similar work [(11,27) ; M. Peschanski the well-recognized inaccuracy of clinical estimation of gestation based on reported last menstruation, alternative and A. Björklund, personal communications]. The additional requirement for abdominal ultrasound, which is strategies have been proposed. Ultrasound may be used, whether during normal fetal development or prior/during found helpful by some (Peschanski, personal communication) and confirmed in our own experience, is consid-TOP, to estimate fetal size measured as "crown-rump length," and this may then be converted to embryonic ered not to be an absolute requirement by others (11). A further requirement for maintaining successful outcome stage or gestational age based on tabulations derived from detailed developmental studies (6, 29, 30) . How-collected using low-pressure aspiration (36), and this is extended in the present study based on a larger series of ever, even with this method a degree of fragmentation of the fetal tissue is inevitable. More recently, Evtouche-140 cases using this method, accompanied by quantitative correlation analysis (Fig. 3) . We have confirmed nko et al. have developed an algorithm based on regression analyses of the size of fetal parts (particularly limb that ultrasound data provide a far more consistent correlation with morphological indices of development than and thorax segments) that can yield improved estimates of gestational age from fetal size combined with addi-does LMP, reinforcing the perspective that this may provide a more accurate index for embryonic staging. In tional observations on maturation of organs and tissues (11). We have previously reported preliminary data on the light of experimental evidence suggesting the critical importance of embryonic age to graft viability, it be-the correlations between morphological, ultrasound, and clinical indices of graft age, based on the first 111 cases comes imperative to refine criteria for accurate staging We accept that the tissue protocols we describe here we are involved in optimizing the amounts and quality 5. Brundin, P. Dissection, preparation, and implantation of human embryonic brain tissue. In: Dunnett S. B.; Björk-of suitable human fetal striatal tissue for clinical use, we lund A., eds. Neural transplantation: A practical approach.
accept that this approach is likely to provide a proof of Oxford: IRL Press; 1992:139-160.
concept, and will pave the way for transplantation using 
